Neoadjuvant treatment of locally advanced rectal cancer - a consensus procedure Comprehensive Cancer Center Brno
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
40258696
DOI
10.48095/ccrvch2025105
PII: 140356
Knihovny.cz E-zdroje
- Klíčová slova
- Chemoradiotherapy, concurrent chemoradiotherapy, immunotherapy, immunotherapy, organ-sparing, rectal cancer, total neoadjuvant therapy,
- MeSH
- konsensus MeSH
- lidé MeSH
- nádory rekta * terapie patologie MeSH
- neoadjuvantní terapie * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Significant changes have recently occurred in the treatment of locally advanced rectal cancer. These include a complete administration of systemic therapy in the neoadjuvant phase of treatment, nonsurgical interventions in case of clinically complete response and using of immunotherapy in patients with the deficiency ofmismatch repair. Although there is no universally accepted treatment standard, the concept of total neoadjuvant therapy, immunotherapy and non-operative management is widely accepted in clinical practice. The care of patients with rectal cancer is multimodal, comprehensive and should be based on consensual recommendations. A uniform approach in diagnostic and therapeutic procedures within the individual departments of the oncology center is a condition for high quality standard care. At the same time, unusual clinical situations and the specific wishes of patients should be taken into account. The listed recommended treatment procedures are a reflection of the efforts to unify patient care with rectal cancer at individual workplaces of the comprehensive oncology center in Brno. Defining general recommendations is not the goal.
Citace poskytuje Crossref.org